Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9097 |
High Similarity |
NPD2801 |
Approved |
0.8758 |
High Similarity |
NPD1511 |
Approved |
0.8671 |
High Similarity |
NPD1934 |
Approved |
0.8645 |
High Similarity |
NPD1512 |
Approved |
0.8625 |
High Similarity |
NPD3882 |
Suspended |
0.8385 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.8274 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.8221 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.8155 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.8155 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.8155 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.814 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.8118 |
Intermediate Similarity |
NPD7054 |
Approved |
0.8084 |
Intermediate Similarity |
NPD1247 |
Approved |
0.807 |
Intermediate Similarity |
NPD7472 |
Approved |
0.8024 |
Intermediate Similarity |
NPD5494 |
Approved |
0.8 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.8 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.7974 |
Intermediate Similarity |
NPD1240 |
Approved |
0.7974 |
Intermediate Similarity |
NPD943 |
Approved |
0.7965 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7962 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.7962 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.7952 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7922 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7922 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7919 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7898 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.7898 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.7874 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7871 |
Intermediate Similarity |
NPD1607 |
Approved |
0.7866 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.7831 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7829 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7826 |
Intermediate Similarity |
NPD6799 |
Approved |
0.7816 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.7798 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.7784 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7771 |
Intermediate Similarity |
NPD651 |
Clinical (unspecified phase) |
0.7751 |
Intermediate Similarity |
NPD919 |
Approved |
0.7722 |
Intermediate Similarity |
NPD2796 |
Approved |
0.7719 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7692 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.7688 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7669 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.7647 |
Intermediate Similarity |
NPD9494 |
Approved |
0.7619 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.76 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.76 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.7578 |
Intermediate Similarity |
NPD2800 |
Approved |
0.7572 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.756 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.7545 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.7531 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.753 |
Intermediate Similarity |
NPD1653 |
Approved |
0.7515 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.7514 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.75 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7484 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.747 |
Intermediate Similarity |
NPD920 |
Approved |
0.7423 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7419 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.7405 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7405 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7401 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.7396 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.7368 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.7365 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7362 |
Intermediate Similarity |
NPD1652 |
Phase 2 |
0.7362 |
Intermediate Similarity |
NPD1243 |
Approved |
0.7349 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7349 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7349 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7349 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.7349 |
Intermediate Similarity |
NPD2534 |
Approved |
0.732 |
Intermediate Similarity |
NPD9269 |
Phase 2 |
0.7283 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7278 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7262 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7261 |
Intermediate Similarity |
NPD1008 |
Clinical (unspecified phase) |
0.7257 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.7239 |
Intermediate Similarity |
NPD2344 |
Approved |
0.7234 |
Intermediate Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.7229 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.7216 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7215 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.7208 |
Intermediate Similarity |
NPD9717 |
Approved |
0.7189 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7179 |
Intermediate Similarity |
NPD1203 |
Approved |
0.717 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7161 |
Intermediate Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.7151 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7143 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.7143 |
Intermediate Similarity |
NPD1933 |
Approved |
0.7135 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.7126 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7117 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.7117 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7108 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7099 |
Intermediate Similarity |
NPD6651 |
Approved |
0.7076 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7066 |
Intermediate Similarity |
NPD2309 |
Approved |
0.7066 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7063 |
Intermediate Similarity |
NPD411 |
Approved |
0.7063 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7059 |
Intermediate Similarity |
NPD9268 |
Approved |
0.7048 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7031 |
Intermediate Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.703 |
Intermediate Similarity |
NPD3540 |
Phase 1 |
0.7012 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.6989 |
Remote Similarity |
NPD6971 |
Discontinued |
0.6982 |
Remote Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.6971 |
Remote Similarity |
NPD5353 |
Approved |
0.697 |
Remote Similarity |
NPD6099 |
Approved |
0.697 |
Remote Similarity |
NPD3539 |
Phase 1 |
0.697 |
Remote Similarity |
NPD6100 |
Approved |
0.6966 |
Remote Similarity |
NPD7199 |
Phase 2 |
0.6949 |
Remote Similarity |
NPD6234 |
Discontinued |
0.6935 |
Remote Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.6933 |
Remote Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.6931 |
Remote Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.6928 |
Remote Similarity |
NPD2346 |
Discontinued |
0.6927 |
Remote Similarity |
NPD3787 |
Discontinued |
0.6905 |
Remote Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.6902 |
Remote Similarity |
NPD7685 |
Pre-registration |
0.6889 |
Remote Similarity |
NPD5242 |
Approved |
0.6889 |
Remote Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.6883 |
Remote Similarity |
NPD1548 |
Phase 1 |
0.6883 |
Remote Similarity |
NPD9545 |
Approved |
0.6867 |
Remote Similarity |
NPD228 |
Approved |
0.6865 |
Remote Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.6863 |
Remote Similarity |
NPD9493 |
Approved |
0.6857 |
Remote Similarity |
NPD6844 |
Discontinued |
0.6852 |
Remote Similarity |
NPD1296 |
Phase 2 |
0.6851 |
Remote Similarity |
NPD2403 |
Approved |
0.6845 |
Remote Similarity |
NPD2654 |
Approved |
0.6833 |
Remote Similarity |
NPD5710 |
Approved |
0.6833 |
Remote Similarity |
NPD5711 |
Approved |
0.6832 |
Remote Similarity |
NPD6832 |
Phase 2 |
0.6818 |
Remote Similarity |
NPD1006 |
Clinical (unspecified phase) |
0.6815 |
Remote Similarity |
NPD1547 |
Clinical (unspecified phase) |
0.6813 |
Remote Similarity |
NPD1019 |
Discontinued |
0.6802 |
Remote Similarity |
NPD5049 |
Phase 3 |
0.68 |
Remote Similarity |
NPD6386 |
Approved |
0.68 |
Remote Similarity |
NPD6385 |
Approved |
0.6784 |
Remote Similarity |
NPD4357 |
Discontinued |
0.6776 |
Remote Similarity |
NPD1241 |
Discontinued |
0.6772 |
Remote Similarity |
NPD1608 |
Approved |
0.6761 |
Remote Similarity |
NPD37 |
Approved |
0.6742 |
Remote Similarity |
NPD4967 |
Phase 2 |
0.6742 |
Remote Similarity |
NPD4965 |
Approved |
0.6742 |
Remote Similarity |
NPD4966 |
Approved |
0.6727 |
Remote Similarity |
NPD4340 |
Discontinued |
0.6725 |
Remote Similarity |
NPD7440 |
Discontinued |
0.672 |
Remote Similarity |
NPD8434 |
Phase 2 |
0.671 |
Remote Similarity |
NPD5536 |
Phase 2 |
0.6709 |
Remote Similarity |
NPD1610 |
Phase 2 |
0.6708 |
Remote Similarity |
NPD2798 |
Approved |
0.6707 |
Remote Similarity |
NPD4062 |
Phase 3 |
0.6707 |
Remote Similarity |
NPD4308 |
Phase 3 |
0.6686 |
Remote Similarity |
NPD824 |
Approved |
0.6686 |
Remote Similarity |
NPD7390 |
Discontinued |
0.6685 |
Remote Similarity |
NPD7228 |
Approved |
0.6685 |
Remote Similarity |
NPD6374 |
Clinical (unspecified phase) |
0.6684 |
Remote Similarity |
NPD6781 |
Approved |
0.6684 |
Remote Similarity |
NPD6778 |
Approved |
0.6684 |
Remote Similarity |
NPD6780 |
Approved |
0.6684 |
Remote Similarity |
NPD6782 |
Approved |
0.6684 |
Remote Similarity |
NPD6776 |
Approved |
0.6684 |
Remote Similarity |
NPD6779 |
Approved |
0.6684 |
Remote Similarity |
NPD6777 |
Approved |
0.6667 |
Remote Similarity |
NPD3018 |
Phase 2 |
0.6667 |
Remote Similarity |
NPD1481 |
Phase 2 |
0.6649 |
Remote Similarity |
NPD8313 |
Approved |
0.6649 |
Remote Similarity |
NPD8312 |
Approved |
0.6647 |
Remote Similarity |
NPD5698 |
Clinical (unspecified phase) |
0.6646 |
Remote Similarity |
NPD3268 |
Approved |
0.6646 |
Remote Similarity |
NPD1470 |
Approved |
0.6645 |
Remote Similarity |
NPD405 |
Clinical (unspecified phase) |
0.6627 |
Remote Similarity |
NPD1471 |
Phase 3 |
0.6626 |
Remote Similarity |
NPD4908 |
Phase 1 |
0.6618 |
Remote Similarity |
NPD2899 |
Discontinued |
0.6613 |
Remote Similarity |
NPD1729 |
Discontinued |
0.6609 |
Remote Similarity |
NPD1940 |
Clinical (unspecified phase) |
0.6607 |
Remote Similarity |
NPD7033 |
Discontinued |
0.6606 |
Remote Similarity |
NPD6233 |
Phase 2 |
0.6604 |
Remote Similarity |
NPD1535 |
Discovery |
0.6598 |
Remote Similarity |
NPD4360 |
Phase 2 |
0.6598 |
Remote Similarity |
NPD4363 |
Phase 3 |
0.6597 |
Remote Similarity |
NPD6842 |
Approved |
0.6597 |
Remote Similarity |
NPD6841 |
Approved |
0.6597 |
Remote Similarity |
NPD6843 |
Phase 3 |
0.6596 |
Remote Similarity |
NPD7549 |
Discontinued |
0.6595 |
Remote Similarity |
NPD2163 |
Approved |
0.6592 |
Remote Similarity |
NPD4288 |
Approved |
0.6592 |
Remote Similarity |
NPD2296 |
Approved |
0.6591 |
Remote Similarity |
NPD6055 |
Clinical (unspecified phase) |
0.6588 |
Remote Similarity |
NPD2424 |
Discontinued |
0.6584
|
Remote Similarity |
NPD3225 |
Approved |